Achieve Life Sciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Achieve Life Sciences, Inc. (ACHV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 20 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2026-08-11
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-12-31 was 0.00 shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2024-09-30 was 25.00 shares.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2025 was 322.20K shares, a 488086.36% increase from fiscal 2024.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2024 was 66.00 shares, a 88.57% increase from fiscal 2023.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2023 was 35.00 shares, a 40.00% increase from fiscal 2022.
- Achieve Life Sciences, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2022 was 25.00 shares, a 1150.00% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 20.00 shares 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-24 | 322.20K shares 10-K · filed 2026-03-24 | |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 322.20K shares 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | 322.20K shares 10-Q · filed 2025-08-07 | |||
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | 25.00 shares derived: sum of 2 quarters · filed 2025-03-11 | 29.00 shares derived: sum of 3 quarters · filed 2025-03-11 | 66.00 shares 10-K · filed 2025-03-11 |
| 2024-09-30 | 25.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 29.00 shares derived: sum of 2 quarters · filed 2024-11-07 | 66.00 shares 10-Q · filed 2024-11-07 | 68.00 shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 4.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 41.00 shares 10-Q · filed 2024-08-13 | 43.00 shares derived: sum of 3 quarters · filed 2024-08-13 | 43.00 shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 37.00 shares 10-Q · filed 2024-05-09 | 39.00 shares derived: sum of 2 quarters · filed 2024-05-09 | 39.00 shares derived: sum of 3 quarters · filed 2024-05-09 | 43.00 shares derived: sum of 4 quarters · filed 2024-05-09 |
| 2023-12-31 | 2.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 2.00 shares derived: sum of 2 quarters · filed 2024-03-28 | 6.00 shares derived: sum of 3 quarters · filed 2024-03-28 | 35.00 shares 10-K · filed 2024-03-28 |
| 2023-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | 4.00 shares derived: sum of 2 quarters · filed 2023-11-09 | 33.00 shares 10-Q · filed 2023-11-09 | 33.00 shares derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | 4.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | 33.00 shares 10-Q · filed 2023-08-14 | 33.00 shares derived: sum of 3 quarters · filed 2023-08-14 | 33.00 shares derived: sum of 4 quarters · filed 2023-08-14 |
| 2023-03-31 | 29.00 shares 10-Q · filed 2023-05-09 | 29.00 shares derived: sum of 2 quarters · filed 2023-05-09 | 29.00 shares derived: sum of 3 quarters · filed 2023-05-09 | |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 0.00 shares derived: sum of 2 quarters · filed 2023-03-16 | 25.00 shares 10-K · filed 2023-03-16 | |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | 25.00 shares 10-Q · filed 2022-11-14 | ||
| 2022-06-30 | 25.00 shares 10-Q · filed 2022-08-11 | |||
| 2021-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | 0.00 shares derived: sum of 2 quarters · filed 2022-03-10 | 2.00 shares 10-K · filed 2022-03-10 | |
| 2021-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 2.00 shares 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | 2.00 shares 10-Q · filed 2021-08-12 | |||
| 2020-12-31 | 28.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | 28.00 shares derived: sum of 2 quarters · filed 2021-03-11 | 30.00 shares 10-K · filed 2021-03-11 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 2.00 shares 10-Q · filed 2020-11-12 | ||
| 2020-06-30 | 2.00 shares 10-Q · filed 2020-08-06 | |||
| 2017-12-31 | -1.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -245.70K shares derived: sum of 2 quarters · filed 2018-03-01 | 10.10K shares derived: sum of 3 quarters · filed 2018-03-01 | 19.54K shares 10-K · filed 2018-03-01 |
| 2017-09-30 | -245.69K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 10.10K shares derived: sum of 2 quarters · filed 2017-11-09 | 19.54K shares 10-Q · filed 2017-11-09 | 997.08K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 255.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | 265.24K shares 10-Q · filed 2017-07-31 | 1.24M shares derived: sum of 3 quarters · filed 2017-07-31 | 1.24M shares derived: sum of 4 quarters · filed 2017-07-31 |
| 2017-03-31 | 9.45K shares 10-Q · filed 2017-05-15 | 986.99K shares derived: sum of 2 quarters · filed 2017-05-15 | 986.99K shares derived: sum of 3 quarters · filed 2017-05-15 | |
| 2016-12-31 | 977.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 977.54K shares derived: sum of 2 quarters · filed 2017-02-23 | 994.06K shares 10-K · filed 2017-02-23 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | 16.52K shares 10-Q · filed 2016-11-10 | ||
| 2016-06-30 | 16.52K shares 10-Q · filed 2016-08-04 | |||
| 2015-12-31 | 247.77K shares 10-K · filed 2017-02-23 | |||
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 0.00 shares derived: sum of 2 quarters · filed 2017-02-23 | 12.17K shares 10-K · filed 2017-02-23 | |
| 2014-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | 12.17K shares 10-Q · filed 2014-10-30 | ||
| 2014-06-30 | 12.17K shares 10-Q · filed 2014-08-07 | |||
| 2013-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | 0.00 shares derived: sum of 2 quarters · filed 2016-03-09 | 0.00 shares derived: sum of 3 quarters · filed 2016-03-09 | 3.06K shares 10-K · filed 2016-03-09 |
| 2013-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | 0.00 shares derived: sum of 2 quarters · filed 2013-11-07 | 3.06K shares 10-Q · filed 2013-11-07 | 27.68K shares derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | 3.06K shares 10-Q · filed 2013-08-08 | 27.68K shares derived: sum of 3 quarters · filed 2015-03-26 | 16.24K shares derived: sum of 4 quarters · filed 2015-03-26 |
| 2013-03-31 | 3.06K shares 10-Q · filed 2013-05-02 | 27.68K shares derived: sum of 2 quarters · filed 2015-03-26 | 16.24K shares derived: sum of 3 quarters · filed 2015-03-26 | |
| 2012-12-31 | 24.62K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | 13.18K shares derived: sum of 2 quarters · filed 2015-03-26 | 12.31K shares 10-K · filed 2015-03-26 | |
| 2012-09-30 | -11.44K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -12.31K shares 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | -868.00 shares 10-Q · filed 2012-08-02 | |||
| 2011-12-31 | 22.99K shares 10-K · filed 2014-03-11 | |||
| 2010-12-31 | 7.31K shares 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |